Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial

Objective To evaluate the impact of an Acceptance and Commitment Therapy (ACT) programme, tailored for people living with type 1 diabetes, on glycated haemoglobin (HbA1c), self-management and psychosocial factors among individuals with HbA1c>60 mmol/mol compared with treatment as usual (TAU)....

Full description

Saved in:
Bibliographic Details
Main Authors: Susanne Amsberg, Ingrid Wijk, Fredrik Livheim, Eva Toft, Unn-Britt Johansson, Therese Anderbro
Format: Article
Language:English
Published: BMJ Publishing Group 2023-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/12/e072061.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720384469860352
author Susanne Amsberg
Ingrid Wijk
Fredrik Livheim
Eva Toft
Unn-Britt Johansson
Therese Anderbro
author_facet Susanne Amsberg
Ingrid Wijk
Fredrik Livheim
Eva Toft
Unn-Britt Johansson
Therese Anderbro
author_sort Susanne Amsberg
collection DOAJ
description Objective To evaluate the impact of an Acceptance and Commitment Therapy (ACT) programme, tailored for people living with type 1 diabetes, on glycated haemoglobin (HbA1c), self-management and psychosocial factors among individuals with HbA1c>60 mmol/mol compared with treatment as usual (TAU).Setting An endocrinologic clinic in Sweden.Participants In this randomised controlled trial, 81 individuals with type 1 diabetes, aged 18–70 years with HbA1c>60 mmol/mol, were randomly assigned to either an ACT group intervention or TAU. Exclusion criteria were: unable to speak Swedish, untreated or severe psychiatric disease, cortisone treatment, untreated thyroid disease and newly started insulin pump therapy. At the 2-year follow-up, HbA1c was measured in 26 individuals.Intervention The ACT programme comprised seven 2-hour sessions held over 14 weeks and focused on acceptance of stressful thoughts and emotions, and to promote value-based committed action.Outcomes The primary outcome was HbA1c, and the secondary outcomes were measures of depression, anxiety, general stress, fear of hypoglycaemia, diabetes distress, self-care activities, psychological flexibility (general and related to diabetes) and quality of life. The primary endpoint was HbA1c 2 years after the intervention programme. Linear mixed models were used to test for an interaction effect between measurement time and group.Results Likelihood ratio test of nested models demonstrated no statistically significant interaction effect (χ2=0.49, p=0.485) between measurement time and group regarding HbA1c. However, a statistically significant interaction effect (likelihood ratio test χ2=12.63, p<0.001) was observed with improved scores on The Acceptance and Action Questionnaire in the intervention group after 1 and 2 years.Conclusions No statistically significant difference was found between the groups regarding the primary outcome measure, HbA1c. However, the ACT programme showed a persistent beneficial impact on psychological flexibility in the intervention group. The dropout rate was higher than expected, which may indicate a challenge in this type of study.Trial registration number NCT02914496.
format Article
id doaj-art-155baa01a51e4a2fa7cee558871fc173
institution DOAJ
issn 2044-6055
language English
publishDate 2023-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-155baa01a51e4a2fa7cee558871fc1732025-08-20T03:11:57ZengBMJ Publishing GroupBMJ Open2044-60552023-12-01131210.1136/bmjopen-2023-072061Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trialSusanne Amsberg0Ingrid Wijk1Fredrik Livheim2Eva Toft3Unn-Britt Johansson4Therese Anderbro5Department of Health Care Sciences, Marie Cederschiöld University, Stockholm, SwedenDepartment of Health Promoting Science, Sophiahemmet University, Stockholm, SwedenDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, SwedenDepartment of Medicine, Huddinge, Karolinska Institutet, Stockholm, SwedenDepartment of Health Promoting Science, Sophiahemmet University, Stockholm, SwedenDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, SwedenObjective To evaluate the impact of an Acceptance and Commitment Therapy (ACT) programme, tailored for people living with type 1 diabetes, on glycated haemoglobin (HbA1c), self-management and psychosocial factors among individuals with HbA1c>60 mmol/mol compared with treatment as usual (TAU).Setting An endocrinologic clinic in Sweden.Participants In this randomised controlled trial, 81 individuals with type 1 diabetes, aged 18–70 years with HbA1c>60 mmol/mol, were randomly assigned to either an ACT group intervention or TAU. Exclusion criteria were: unable to speak Swedish, untreated or severe psychiatric disease, cortisone treatment, untreated thyroid disease and newly started insulin pump therapy. At the 2-year follow-up, HbA1c was measured in 26 individuals.Intervention The ACT programme comprised seven 2-hour sessions held over 14 weeks and focused on acceptance of stressful thoughts and emotions, and to promote value-based committed action.Outcomes The primary outcome was HbA1c, and the secondary outcomes were measures of depression, anxiety, general stress, fear of hypoglycaemia, diabetes distress, self-care activities, psychological flexibility (general and related to diabetes) and quality of life. The primary endpoint was HbA1c 2 years after the intervention programme. Linear mixed models were used to test for an interaction effect between measurement time and group.Results Likelihood ratio test of nested models demonstrated no statistically significant interaction effect (χ2=0.49, p=0.485) between measurement time and group regarding HbA1c. However, a statistically significant interaction effect (likelihood ratio test χ2=12.63, p<0.001) was observed with improved scores on The Acceptance and Action Questionnaire in the intervention group after 1 and 2 years.Conclusions No statistically significant difference was found between the groups regarding the primary outcome measure, HbA1c. However, the ACT programme showed a persistent beneficial impact on psychological flexibility in the intervention group. The dropout rate was higher than expected, which may indicate a challenge in this type of study.Trial registration number NCT02914496.https://bmjopen.bmj.com/content/13/12/e072061.full
spellingShingle Susanne Amsberg
Ingrid Wijk
Fredrik Livheim
Eva Toft
Unn-Britt Johansson
Therese Anderbro
Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
BMJ Open
title Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
title_full Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
title_fullStr Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
title_full_unstemmed Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
title_short Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
title_sort impact of an acceptance and commitment therapy programme on hba1c self management and psychosocial factors in adults with type 1 diabetes and elevated hba1c levels a randomised controlled trial
url https://bmjopen.bmj.com/content/13/12/e072061.full
work_keys_str_mv AT susanneamsberg impactofanacceptanceandcommitmenttherapyprogrammeonhba1cselfmanagementandpsychosocialfactorsinadultswithtype1diabetesandelevatedhba1clevelsarandomisedcontrolledtrial
AT ingridwijk impactofanacceptanceandcommitmenttherapyprogrammeonhba1cselfmanagementandpsychosocialfactorsinadultswithtype1diabetesandelevatedhba1clevelsarandomisedcontrolledtrial
AT fredriklivheim impactofanacceptanceandcommitmenttherapyprogrammeonhba1cselfmanagementandpsychosocialfactorsinadultswithtype1diabetesandelevatedhba1clevelsarandomisedcontrolledtrial
AT evatoft impactofanacceptanceandcommitmenttherapyprogrammeonhba1cselfmanagementandpsychosocialfactorsinadultswithtype1diabetesandelevatedhba1clevelsarandomisedcontrolledtrial
AT unnbrittjohansson impactofanacceptanceandcommitmenttherapyprogrammeonhba1cselfmanagementandpsychosocialfactorsinadultswithtype1diabetesandelevatedhba1clevelsarandomisedcontrolledtrial
AT thereseanderbro impactofanacceptanceandcommitmenttherapyprogrammeonhba1cselfmanagementandpsychosocialfactorsinadultswithtype1diabetesandelevatedhba1clevelsarandomisedcontrolledtrial